Litigation Details for Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc. (D. Del. 2019)
✉ Email this page to a colleague
Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc. (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-10-15 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | None | Referred To | |
| Parties | H. LUNDBECK A/S | ||
| Patents | 10,307,419; 7,888,362; 8,349,840; 8,618,109; 9,839,637 | ||
| Attorneys | Erin M. Sommers | ||
| Firms | Stamoulis & Weinblatt LLC | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Otsuka Pharmaceutical Co., Ltd. v. Prinston Pharmaceutical Inc. (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-07-08 | 17 | Redacted Document | pleadings of non-infringement of U.S. Patent 10,307,419 (“the ’419 patent”). Prinston’s proposed brexpiprazole… 461 patents, including the ’419 patent. (D.I. 1, Ex. G (the ’419 patent)). The ’419 patent issued … Notably, the ’419 patent expires years after the other patents asserted in this litigation,…only patent directed to specific formulations with specific obvious excipients. The other patents- in-suit…Literally Infringe the ’419 Patent Both independent claims of the ’419 patent cover, in pertinent part | External link to document |
| 2020-08-03 | 24 | Redacted Document | 109 patent”); 9,839,637 (“the ’637 patent”); and 10,307,419 (“the ’419 patent”). The ’419 patent relates…end this litigation. U.S. Patent No. 10,307,419 is just one of five patents asserted against Prinston.… United States Patent Nos. 7,888,362 (“the ’362 patent”); 8,349,840 (“the ’840 patent”); 8,618,109 (“…to the ’419 patent, original claim 1 recited HPC as a binder. Ex. 7 (Original U.S. Patent Application…NATURE AND STAGE OF THE PROCEEDINGS This patent infringement action arises from Prinston’s filing | External link to document |
| 2019-10-15 | 4 | Patent/Trademark Report to Commissioner of Patents | ,349,840 ;8,618,109 ;9,839,637 ;10,307,419. (lak) (Entered: 10/16/2019) 15 October 2019 PACER … Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362 ;8,349,840… 15 October 2019 1:19-cv-01956 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
